Alberto Molano, PhD,  —

Certain patterns of brain activity can predict early on the probability of cognitive decline in young mice at high genetic risk of developing Alzheimer’s disease, a study has found. The findings, “Early Hippocampal Sharp-Wave Ripple Deficits Predict Later Learning and Memory Impairments in an Alzheimer’s Disease…

INmune Bio has dosed the first patient in its Phase 1b trial (NCT03943264) testing the safety and efficacy of its next-generation anti-inflammatory compound XPro1595 for Alzheimer’s disease (AD). The trial is currently recruiting in different sites across Australia. More information can be found here. Instead…